ARRY

Array BioPharma Inc. - Common Stock

$11.51 +$0.22 +1.88%


Own 3 of ARRY at $10.49

Shares Bought7
Shares Sold4
Total11
Shares Owned3
Last Price$11.51
Total Return$6.01
Range Today$11.22 - $11.64
52 Week Range$3.49 - $13.40
Open$11.29
Market Cap$1.93B
Volume/Average1.34M/4.79M
P/E Ratio-
Dividend/Yield-




Array BioPharma, Inc. engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, ONT-380 (ARRY-380), ARRY-797, Ipatasertib, Motolimod, Danoprevir, ARRy-614, GDC-0994, and LOXO-101. Its drugs focuses on the treatment of cancer and inflammatory diseases. The company was founded by Kevin Koch, Anthony Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.


Orders

Date Side Shares Price
09-08-2017 16:21:34 buy 1 $11.02
09-08-2017 16:30:59 buy 1 $10.95
09-08-2017 17:46:50 buy 1 $11.48
09-11-2017 13:28:13 sell 1 $11.85
09-11-2017 13:29:56 sell 1 $11.85
09-11-2017 13:31:00 sell 1 $11.82
09-13-2017 18:00:04 buy 1 $10.49
09-13-2017 18:11:11 buy 1 $10.46
09-13-2017 18:18:29 buy 1 $10.49
09-13-2017 18:23:02 buy 1 $10.50
09-19-2017 14:45:04 sell 1 $11.38